Results 211 to 220 of about 278,227 (245)

Statin Use and the Risk of Developing Graves' Orbitopathy in Patients With Graves' Disease: A Systematic Review and Meta-Analysis With Regional and Gender-Stratified Analyses. [PDF]

Cureus
Kermaj M, Hakkeem B, Fero H, Doddapaneni VK, Ylli A.   +4 more
europepmc   +1 more source

Sarilumab in the management of Graves orbitopathy with low clinical activity scores [PDF]

J.V. Pérez-Moreiras, Dolores Abelenda, Joana Providência, Guilherme Castela   +3 more
openalex   +1 more source

Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation. [PDF]

J Endocrinol Invest
Yang W, Xu X, Xie R, Lin J, Hou Z, Xin Z, Cao X, Shi T.   +7 more
europepmc   +1 more source

Graves' Orbitopathy: Report of 82 cases.

, 2021
Samah Mbarek, Fatma Ben Abid, Wafa Ammari, Wafa Alaya, Anis Mahmoud, R. Messaoud   +5 more
openalex   +1 more source

Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]

BMJ Open Ophthalmol
Abounoori M, Pourazizi M, Bahmani Kashkouli M, Akha O, Jafari R, Movahedirad M.   +5 more
europepmc   +1 more source

Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]

Sultan Qaboos Univ Med J
Alfutaisi A, Osman A, Al Siyabi ZS, Al Senani OS, Bahowairath F, Al Farqani A, Al Rasbi SK.   +6 more
europepmc   +1 more source

Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy. [PDF]

Graefes Arch Clin Exp Ophthalmol
Sawicka-Gutaj N, Stańska A, Stański M, Gruszczyński D, Zawalna N, Pochylski M, Ruchała M.   +6 more
europepmc   +1 more source

Ocular surface disease index in Graves' orbitopathy: a cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Maglionico MN, Lanzolla G, Figus M, Cosentino G, Comi S, Marinò M, Santini F, Posarelli C.   +7 more
europepmc   +1 more source

Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]

Int J Ophthalmol
Jian H, Ma RX, He WM.
europepmc   +1 more source

Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim C, Park JH, Choi YJ, Jun HO, Chung JK, Park TK, Yoon JS, Yang JW, Jang SY.   +8 more
europepmc   +1 more source